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Most of the t(3;14)(q27;q32) where molecular genetics 
studies were performed showed the involvement of 
IGH@ and BCL6. It is unknown if the prognoses are 
different. 
Clinics and pathology 
Disease 
Non Hodgkin lymphoma 
Clinics 
Four cases available to date: a case of primary gastric 
lymphoma (Xu et al., 2000); a gastric diffuse large B-
cell lymphoma with residual MALT lymphoma 
(DLCLML) case (Chen et al., 2006), a case of primary 
central nervous system lymphoma (PCNSL, a diffuse 
large B cell lymphoma confined to the brain) 
(Montesinos-Rongen et al., 2003), and another 
lymphoma case (Akasaka et al., 2000). 





706 amino acids; composed of a NH2-term BTB/POZ 
domain (amino acids 1-130 (32-99 according to Swiss-
Prot) which mediates homodimerization and protein-
protein interactions with other corepressors (including 
HDAC1 and NCOR2/SMRT to constitute a large 
repressing complex, another transcription repression  
domain (191-386), PEST sequences (300-417) with a  
 
KKYK motif (375-379), and six zinc finger at the C-
term (518-541, 546-568, 574-596, 602-624, 630-652, 
658-681), responsible for sequence specific DNA 
binding. Transcription repressor; recognizes the 
consensus sequence: TTCCT(A/C)GAA (Albagli-
Curiel, 2003). Role in germinal centers of lymphoid 
follicles. BCL6 prevents ATM and TP53 to induce 
apoptosis in response to DNA rearrangements such as 
somatic hypermutation and class switch recombinatio. 





HSP90AA1 is also known as HSP90. Molecular 
chaperone. Possesses an ATP binding site with intrinsic 
ATPase activity that regulates its conformation. 
Promotes the maturation, structural maintenance and 
regulation of specific target proteins called 'client' 
proteins. Maintains protein homeostasis. 
HSP90AA1/HSP90 interacts with regions of client 
proteins where protein folding clefts merge. Folding 
clefts are a general topological feature of proteins i  
native conformation, and many of these hydrophobic 
clefts, must open to permit access of ligands. 
HSP90AA1/HSP90 stabilizes the open cleft, impeding 
further unfolding and Hsp70-dependent ubiquitination 
(Pratt et al., 2010). HSP90AA1/HSP90 and its 
associated co-chaperones facilitate a precise and 
efficient working environment beneficial for telomere 
function (DeZwaan and Freeman, 2010). 
HSP90AA1/HSP90 is exploited by cancer cells to 
support the activated and/or metastable forms of 
oncoproteins, and to buffer cellular stresses induce  by 
the malignancy. Hsp90 is often overexpressed in cancer 
cells (Neckers and Workman, 2012). 
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The break occurs in HSP90AA1 intron 1, resulting in 
the exchange of the first non-coding exons of 
HSP90AA1 and BCL6. 
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